Anna Schmitt
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Glioma Diagnosis and Treatment
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 21
- Hematology 17
- Chronic Myeloid Leukemia Treatments 9
- Multiple Myeloma Research and Treatments 7
- Co-authors
- Noel Jean Milpied (4 shared papers)Manuel Devesa (1 shared paper)Michel Cogné (1 shared paper)Isabelle Soubeyran (1 shared paper)Jean Feuillard (1 shared paper)Jean‐Philippe Merlio (1 shared paper)Nathalie Gachard (1 shared paper)Abdelghafour Marfak (1 shared paper)
- Journals
- Blood (10 papers)Hematological Oncology (4 papers)Haematologica (4 papers)Cancer Medicine (2 papers)Leukemia (2 papers)
- Partner nations
- FranceUnited StatesRéunion
In The Last Decade
Anna Schmitt
48 papers receiving 1.4k citations
Anna Schmitt's Hit Papers
Peers
Comparison fields: 5 of 61
- Genetics 448
- Pathology and Forensic Medicine 661
- Neurology 472
- Hematology 202
- Oncology 408
Countries citing papers authored by Anna Schmitt
This map shows the geographic impact of Anna Schmitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Schmitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Schmitt more than expected).
Fields of papers citing papers by Anna Schmitt
This network shows the impact of papers produced by Anna Schmitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Schmitt. The network helps show where Anna Schmitt may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Schmitt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial Hit paper breakdown → | 2020 | 460 |
| 2 | 2020 | 179 | |
| 3 | 2012 | 140 | |
| 4 | 2022 | 73 | |
| 5 | 2022 | 60 | |
| 6 | 2013 | 54 | |
| 7 | 2019 | 40 | |
| 8 | 2016 | 37 | |
| 9 | 2015 | 36 | |
| 10 | 2018 | 36 | |
| 11 | 2021 | 34 | |
| 12 | 2019 | 33 | |
| 13 | 2020 | 32 | |
| 14 | 2020 | 29 | |
| 15 | 1999 | 24 | |
| 16 | 2022 | 19 | |
| 17 | 2019 | 16 | |
| 18 | 2022 | 16 | |
| 19 | 2023 | 15 | |
| 20 | 2020 | 14 |
About Anna Schmitt
Anna Schmitt is a scholar working on Pathology and Forensic Medicine, Hematology, Genetics, Neurology and Oncology, having authored 48 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (21 papers), CNS Lymphoma Diagnosis and Treatment (15 papers), Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (8 papers), Multiple Myeloma Research and Treatments (7 papers), Glioma Diagnosis and Treatment (6 papers), Acute Lymphoblastic Leukemia research (4 papers) and Cancer-related gene regulation (4 papers). The work is most often cited by research in Genetics (448 citations), Pathology and Forensic Medicine (661 citations), Neurology (472 citations), Hematology (202 citations) and Oncology (408 citations). Anna Schmitt has collaborated with scholars based in France, United States and Réunion. Frequent co-authors include Noel Jean Milpied, Manuel Devesa, Michel Cogné, Isabelle Soubeyran, Jean Feuillard, Jean‐Philippe Merlio, Nathalie Gachard, Abdelghafour Marfak, Pierre Soubeyran and Barbara Petit. Their work appears in journals such as Blood, Hematological Oncology, Haematologica, Cancer Medicine and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.